• Research report

Examining vulnerability to foodborne illness: A comprehensive review of “clinically vulnerable groups"

Content: Research report

Examining vulnerability to foodborne illness A comprehensive review of “clinically vulnerable groups"

PDF | 4.0MB

Content guide

List of tables

Table 1. Search terms with thematic blocks combined using the “AND” operator

Table 2. Prevalence of five key foodborne pathogens in Scotland according to clinically vulnerable groups. (Percentage of cases reported to be among clinically vulnerable groups)

Table 3. List of countries in included prevalence studies (n=138)

Table 4 Inclusion of data detailing key pathogens and clinically vulnerable groups in reviewed studies (n=138)

Table 5. Incidence rates of foodborne pathogens among clinically vulnerable groups from reviewed studies (number of cases per 100,000 people)

Table 6 Prevalence of foodborne pathogens among pregnant individuals and neonates in reviewed studies (n=37) (L. monocytogenes n=37; Salmonella n=0; Campylobacter n=0; E. coli n=0; Norovirus n=0)

Table 7. Prevalence of foodborne pathogens among children in reviewed studies (n=72) (L. monocytogenes n=12; Salmonella n=34; Campylobacter n=22; E. coli n=21; norovirus n=3)

Table 8. Prevalence of foodborne pathogens among older adults in reviewed studies (n=84) (L. monocytogenes n=49; Salmonella n=21; Campylobacter n=9; E. coli n=11; norovirus n=2)

Table 9. Prevalence of foodborne pathogens associated with proton pump inhibitor use in reviewed studies (n=12) (L. monocytogenes n=5; Salmonella n=3; Campylobacter n=4; E. coli n=0; norovirus n=0)

Table 10. Prevalence of foodborne pathogens among people with rheumatoid arthritis in reviewed studies (n=8) (L. monocytogenes n=6; Salmonella n=2; Campylobacter n=0; E. coli n=0; norovirus n=0)

Table 11. Prevalence of foodborne pathogens among people with diabetes in reviewed studies (n=20) (L. monocytogenes n=19; Salmonella n=1; Campylobacter n=0; E. coli n=0; norovirus n=0)

Table 12. Prevalence of foodborne pathogens associated with people with IBD in reviewed studies (n=4) (L. monocytogenes n=3; Salmonella n=0; Campylobacter n=1; E. coli n=0; norovirus n=0)

Table 13. Prevalence of foodborne pathogens among people with cancer in reviewed studies (n=29) (L. monocytogenes n=27; Salmonella n=2; Campylobacter n=0; E. coli n=0; norovirus n=0)

Table 14. Prevalence of foodborne pathogens among people with HIV/AIDS in studies (n=10) (L. monocytogenes n=8; Salmonella n=2; Campylobacter n=0; E. coli n=0; norovirus n=0)

Table 15. Prevalence of foodborne pathogens associated with alcohol-related disorders in reviewed studies (n=11) (L. monocytogenes n=10; Salmonella n=1; Campylobacter n=0; E. coli n=0; norovirus n=0)

Table 16. Prevalence of foodborne pathogens associated with transplantation in reviewed studies (n=9) (L. monocytogenes n=7; Salmonella n=1; Campylobacter n=1; E. coli n=0; norovirus n=0)

Table 17. Prevalence of foodborne pathogens associated with medication in reviewed studies (n=21) (L. monocytogenes n=17; Salmonella n=1; Campylobacter n=3; E. coli n=0; norovirus n=0)

Table 18. Proportion of listeriosis cases among individuals with underlying conditions.

Table 19. Summary of physiological factors contributing to increased susceptibility to foodborne infections and prevalence ranges (%) of key pathogens among clinically vulnerable groups (n=138)clinically vulnerable group (n=138) (*denotes no data available)

Table 20. Details of countries and organisations where definitions were obtained from (n=660)

Table 21. Types of resources definitions were obtained from (n=660)

Table 22. Foodborne pathogens referred to in relation to clinically vulnerable groups (n=660)

Table 23. Groups acknowledged as being clinically vulnerable to foodborne pathogens in definitions (n=660)

Table 24 Definitions that referenced clinically vulnerable groups in relation to specific pathogens.

Previous

Executive summary

Next

List of figures
Did you find this helpful? We would love to hear from you.
Thank you for your feedback!

If you like you can share this page with others: